Comparative effectiveness and safety of edoxaban versus warfarin in patients with atrial fibrillation: A nationwide cohort study.

Peter Brønnum NielsenMette SøgaardMartin JensenAnne G OrdingGregory Yh Lip

Published in: International journal of stroke : official journal of the International Stroke Society (2021)

Edoxaban 60 mg is a safe and effective treatment compared with warfarin for stroke prevention in routine clinical care for Danish (mainly Caucasian) patients with AF, with non-significantly different risks for stroke and clinically relevant bleeding, but lower all-cause mortality.

Keyphrases

atrial fibrillation
direct oral anticoagulants
oral anticoagulants
venous thromboembolism
healthcare
palliative care
quality improvement
clinical practice
human health
risk assessment
climate change
cerebral ischemia